A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas.
Current global recommendations for routine malaria chemoprophylaxis in pregnant women living in endemic malarious areas are not clear. To assist in policy formulation, the evidence from randomized controlled trials was reviewed. The literature was extensively searched, and studies identified were systematically analysed in relation to outcomes in the mother and the baby. Routine chemoprophylaxis appears to have an effect on antenatal morbid episodes and packed cell volume. There is a trend towards higher birth-weight values in chemoprophylaxis groups, which reached statistical significance in some studies. Evidence of an effect on gestation was only examined in one study. The effects on perinatal and neonatal mortality have only been examined in a few studies, with small sample sizes. The analysis questions whether routine malaria chemoprophylaxis is the best use of scarce resources in developing countries, and suggests that chemoprophylaxis might be targeted at anaemic women and primigravidae. Large controlled trials, with treatment available to placebo groups, are required to test whether routine chemoprophylaxis has advantages over early, effective treatment of clinical malaria.
Garner
P
P
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, England.
Brabin
B
B
D000962:Antimalarials / Q000627:therapeutic use*; D001724:Birth Weight; D005260:Female; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D016778:Malaria, Falciparum / Q000517:prevention & control*; D010298:Parity; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control*; D011256:Pregnancy Outcome; D016032:Randomized Controlled Trials as Topic
D000962:Antimalarials